PlainRecalls
FDA Drug Moderate Class II Terminated

Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.

Reported: August 17, 2022 Initiated: August 2, 2022 #D-1328-2022

Product Description

Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.

Reason for Recall

Lack of Assurance of Sterility: Complaints received of defective container closure.

Details

Recalling Firm
CIPLA
Units Affected
7,992 bottles
Distribution
Nationwide in the USA
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.. Recalled by CIPLA. Units affected: 7,992 bottles.
Why was this product recalled?
Lack of Assurance of Sterility: Complaints received of defective container closure.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 17, 2022. Severity: Moderate. Recall number: D-1328-2022.